Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$149.99

$74.99/År

Prøve GULL - Gratis

Gå ubegrenset med Magzter GOLD

Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare

$NaN

$NaN/År

Skynd deg, tilbud i begrenset periode!

Timer

minutter

sekunder

BioTecNika - May 2015

Gå ubegrenset med Magzter GOLD

Lese BioTecNika sammen med 9000+ andre magasiner og aviser med bare ett abonnement

Se katalog

1 måned

$14.99

1 år $149.99

$74.99

$6/month

Save 50%
Hurry, Offer Ends in 10 Days

(OR)

Abonner kun på BioTecNika

Gave BioTecNika

Avbryt når som helst.

(Ingen forpliktelser) ⓘ

Hvis du ikke er fornøyd med abonnementet, kan du sende oss en e-post på help@magzter.com innen 7 dager etter abonnementets startdato for full refusjon. Ingen spørsmål - lover! (Merk: Gjelder ikke for enkeltutgavekjøp)

Digitalt abonnement

Øyeblikkelig tilgang ⓘ

Abonner nå for å begynne å lese umiddelbart på Magzter-nettstedet, iOS, Android og Amazon-appene.

Verifisert sikker

betaling ⓘ

Magzter er en verifisert Authorize.Net-forhandler. Les mer

I dette nummeret

The Indian biotech sector faced a major turn of events when Daiichi Sankyo, Japanese firm whose hide and seek with Indian drug company Ranbaxy came to an end as it decided to sell off its entire holding of Sun Pharmaceutical Industries and exit Indian pharma sector after a struggle of eight years. Why it had to offload Ranbaxy and what is in store with the company’s future businesses, find out in Biotecnika magazine’s May 2015 issue. Other stories to keep reader’s interest intact are “India succumbs to H1N1”, “Are we amid biotech bubble”, “Is it time to kill your R&D project?” and much more. Biotecnika bureau had a chance to interact with Ms. Anu Acharya, CEO, Mapmygenome on her entrepreneurial voyage and Dr. Anurag Mathur, Lead author, “Heart-on-chip” on his recent research. Grab your copy to find out what they had to say!

BioTecNika Description:

Forlegger: Biotecnika-Info-Labs-Pvt-Ltd

Kategori: Education

Språk: English

Hyppighet: Monthly

The essential guide to all the news in biotechnology industry & Academia run by India's Most popular Biotechnology Portal www.biotecnika.org. BioTecNika has access to world’s most influential Biotech entrepreneurs, Businesses and institutions. The magazine showcases all this via exclusive features that are insightful, informative and presented with style.

Distinguished by its indepth analysis and latest information, BioTecNika has been an indispensable part of life of Biotechies for over 8+ years. Our well-heeled readership shape opinions and trends in India and across the region. This affluent and influential group is almost impossible to reach - except through the pages of BioTecNika